RxDoctor Payments Data

Larry Elkins, MD

Family Medicine · Newland, NCNPI 1154415628

Payments from drug & device makers

$1,116in general payments, 2019–2025

Across 61 payments — averaging $18.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$202
  • Lilly USA, LLC$173
  • Mylan Specialty L.p.$122
  • AbbVie$119
  • Novo Nordisk$111
  • Otsuka America Pharmaceutical, Inc.$107
  • plus $283 from 8 others

What the payments were for

  • Food & beverage$1,116100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,116 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$442
Medicare patients
28
Services billed
51

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol29$22,318
JanuviaSitagliptin Phosphate28$19,888
EliquisApixaban21$18,595
OzempicSemaglutide19$18,457
MounjaroTirzepatide15$16,356
Spiriva HandihalerTiotropium Bromide17$13,409
JardianceEmpagliflozin15$13,039
Tresiba Flextouch U-200Insulin Degludec17$9,875
SymbicortBudesonide/Formoterol Fumarate26$9,452
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$9,087
Combivent RespimatIpratropium/Albuterol Sulfate14$8,847
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen139$4,602
Albuterol Sulfate HfaAlbuterol Sulfate157$4,135
Humalog Kwikpen U-100Insulin Lispro22$2,913
Dexlansoprazole DrDexlansoprazole14$2,881

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort$30$31,77055 claims
PfizerEliquis$44$18,59521 claims
Novo NordiskOzempic$111$18,45719 claims
Lilly USA, LLCMounjaro$173$16,35615 claims
AbbVieSynthroid$119$2,44929 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Newland

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →